Search Page

1

Cite

Share

Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register.

Listing J, Strangfeld A, Rau R, Kekow J, Gromnica-Ihle E, Klopsch T, Demary W, Burmester GR, Zink A. Listing J, et al. Among authors: strangfeld a. Arthritis Res Ther. 2006;8(3):R66. doi: 10.1186/ar1933. Epub 2006 Apr 5. Arthritis Res Ther. 2006. PMID: 16600016 Free PMC article.

Cite

Share

2

Cite

Share

Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980-88.

Kiessling U, Döring E, Listing J, Meincke J, Schöntube M, Strangfeld A, Zink A. Kiessling U, et al. Among authors: strangfeld a. J Rheumatol. 1998 Sep;25(9):1837-43. J Rheumatol. 1998. PMID: 9733469

Cite

Share

3

Cite

Share

Infections in patients with rheumatoid arthritis treated with biologic agents.

Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A. Listing J, et al. Among authors: strangfeld a. Arthritis Rheum. 2005 Nov;52(11):3403-12. doi: 10.1002/art.21386. Arthritis Rheum. 2005. PMID: 16255017

Cite

Share

4

Cite

Share

[Dose adjustment in patients treated with infliximab in routine rheumatologic care in Germany. Results from the Biologics Register RABBIT].

Zink A, Listing J, Strangfeld A, Gromnica-Ihle E, Demary W, Schneider M. Zink A, et al. Among authors: strangfeld a. Z Rheumatol. 2006 Sep;65(5):441-6. doi: 10.1007/s00393-006-0033-8. Z Rheumatol. 2006. PMID: 16534537 German.

Cite

Share

5

Cite

Share

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.

Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Listing J. Zink A, et al. Among authors: strangfeld a. Arthritis Rheum. 2006 Nov;54(11):3399-407. doi: 10.1002/art.22193. Arthritis Rheum. 2006. PMID: 17075823

Cite

Share

6

Cite

Share

Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy.

Strangfeld A, Listing J. Strangfeld A, et al. Best Pract Res Clin Rheumatol. 2006 Dec;20(6):1181-95. doi: 10.1016/j.berh.2006.08.010. Best Pract Res Clin Rheumatol. 2006. PMID: 17127203 Review.

Cite

Share

7

Cite

Share

Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Listing J, Strangfeld A, Kekow J, Schneider M, Kapelle A, Wassenberg S, Zink A. Listing J, et al. Among authors: strangfeld a. Arthritis Rheum. 2008 Mar;58(3):667-77. doi: 10.1002/art.23281. Arthritis Rheum. 2008. PMID: 18311816

Cite

Share

8

Cite

Share

Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.

Strangfeld A, Hierse F, Kekow J, von Hinueber U, Tony HP, Dockhorn R, Listing J, Zink A. Strangfeld A, et al. Ann Rheum Dis. 2009 Dec;68(12):1856-62. doi: 10.1136/ard.2008.098467. Epub 2009 Jan 6. Ann Rheum Dis. 2009. PMID: 19126559

Cite

Share

9

Cite

Share

Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.

Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A. Strangfeld A, et al. JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146. JAMA. 2009. PMID: 19224750

Cite

Share

10

Cite

Share

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.

Strangfeld A, Hierse F, Rau R, Burmester GR, Krummel-Lorenz B, Demary W, Listing J, Zink A. Strangfeld A, et al. Arthritis Res Ther. 2010;12(1):R5. doi: 10.1186/ar2904. Epub 2010 Jan 8. Arthritis Res Ther. 2010. PMID: 20064207 Free PMC article.

Cite

Share